Medbright Ai Invts Inc.
MBAIF · OTC
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.02 | 0.04 | -0.00 | -0.00 |
| FCF Yield | -2.31% | 0.00% | -2.76% | -19.74% |
| EV / EBITDA | 0.00 | -15.51 | 0.76 | 0.09 |
| Quality | ||||
| ROIC | 0.00% | -3.38% | -6.70% | -8.33% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | -0.35 | -0.03 | 0.01 | 0.61 |
| Growth | ||||
| Revenue 3-Year CAGR | -83.46% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | 0.00% | 0.00% | -145.60% | 76.53% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | -0.04 | 0.02 | 0.14 |
| Interest Coverage | 0.00 | 0.00 | -2,442.92 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |